MolecuLight® Imaging Significantly Improves Outcomes and Cuts Costs for Deep Sternal Wound Infections in Taiwan Study; Signals Expansion into Surgical Applications

June 12, 2025 -

Toronto, CANADA and Taipei, TAIWAN – June 12, 2025 – MolecuLight Inc., a global pioneer in point-of-care fluorescence imaging for wound care, and its Taiwanese distributor, Healtdeva Company Ltd., congratulate researchers at Shuang-Ho Hospital in Taipei, Taiwan on their publication of groundbreaking findings using MolecuLight. The

Read More

MolecuLight Unveils Thermal Imaging for DX™ Platform, Delivering Measurement, Bacterial & Thermal Assessment in One Device, and Showcases Clinical Evidence at SAWC Spring

April 30, 2025 -

Toronto, Canada – April 30, 2025 – MolecuLight Inc., a global pioneer in point-of-care fluorescence imaging for rapid detection of infection causing bacteria in wounds, today announced the immediate availability of its new Thermal Imaging Module for the MolecuLightDX™ fluorescence imaging platform. This innovative clip-on module allows

Read More

MolecuLight Showcases Advanced Wound Care Imaging at 2025 CAMPS Meeting

February 28, 2025 -

Pittsburgh, PA – 2/28/2025 – MolecuLight Inc., the leader in point-of-care fluorescence imaging devices for wound care, is excited to announce its participation in the 2025 Cellular, Acellular, and Matrix-like Products (CAMPs) Wound Care Summit, held from February 28th to March 2nd in Fort Lauderdale, Florida. In

Read More

Previous